Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ACST TSE:APS CVE:GSD CVE:LTY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACSTAcasti PharmaC$0.58+1.8%C$0.58C$0.47▼C$1.66C$18.19M1.226,576 shs2,450 shsAPSAptose BiosciencesC$2.40C$2.28C$1.21▼C$2.59C$6.13M-1.2882653,887 shs2,945 shsGSDDevonian Health GroupC$7.01-30.3%C$9.92C$5.10▼C$15.00C$19.50M0.4377761,101 shs321 shsLTYLiberty BiopharmaC$2.00+∞C$2.00C$0.06▼C$2.74C$21.54MN/A23,286 shs700 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACSTAcasti Pharma0.00%0.00%0.00%0.00%0.00%APSAptose Biosciences0.00%0.00%+9.09%+1.27%+4.80%GSDDevonian Health Group0.00%+11.78%-0.40%+0.50%+11.78%LTYLiberty Biopharma0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACSTAcasti PharmaC$0.58+1.8%C$0.58C$0.47▼C$1.66C$18.19M1.226,576 shs2,450 shsAPSAptose BiosciencesC$2.40C$2.28C$1.21▼C$2.59C$6.13M-1.2882653,887 shs2,945 shsGSDDevonian Health GroupC$7.01-30.3%C$9.92C$5.10▼C$15.00C$19.50M0.4377761,101 shs321 shsLTYLiberty BiopharmaC$2.00+∞C$2.00C$0.06▼C$2.74C$21.54MN/A23,286 shs700 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACSTAcasti Pharma0.00%0.00%0.00%0.00%0.00%APSAptose Biosciences0.00%0.00%+9.09%+1.27%+4.80%GSDDevonian Health Group0.00%+11.78%-0.40%+0.50%+11.78%LTYLiberty Biopharma0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACSTAcasti Pharma 0.00N/AN/AN/AAPSAptose Biosciences 2.00HoldN/AN/AGSDDevonian Health Group 0.00N/AN/AN/ALTYLiberty Biopharma 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACSTAcasti PharmaC$2.71M6.71C$0.93 per share0.63C$1.56 per share0.37APSAptose BiosciencesN/AN/AC$1.50 per share1.60C($13.59) per shareN/AGSDDevonian Health GroupC$3.00M6.51C$1.15 per share6.10C$0.09 per share77.89LTYLiberty BiopharmaN/AN/AC$0.00 per share2,000.00C$0.79 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACSTAcasti Pharma-C$10.54M-C$0.48N/AN/AN/A-455.58%-67.58%-8.25%N/AAPSAptose Biosciences-C$154.69M-C$10.41N/AN/AN/AN/A115.24%-136.29%N/AGSDDevonian Health Group-C$3.17M-C$2.25N/AN/AN/A-32.50%-23.31%-8.12%N/ALTYLiberty BiopharmaN/A-C$0.16N/AN/AN/AN/AN/AN/AN/ALatest APS, LTY, GSD, and ACST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026APSAptose BiosciencesN/A-C$4.16N/A-C$4.16N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthACSTAcasti PharmaN/AN/AN/AN/AN/AAPSAptose BiosciencesN/A0.39%N/AN/AN/AGSDDevonian Health GroupN/AN/AN/AN/AN/ALTYLiberty BiopharmaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACSTAcasti PharmaN/A4.139.41APSAptose Biosciences-98.740.555.41GSDDevonian Health Group16.361.077.82LTYLiberty Biopharma8.190.120.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACSTAcasti Pharma0.11%APSAptose Biosciences0.02%GSDDevonian Health GroupN/ALTYLiberty BiopharmaN/AInsider OwnershipCompanyInsider OwnershipACSTAcasti Pharma20.28%APSAptose Biosciences17.11%GSDDevonian Health Group14.20%LTYLiberty BiopharmaN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACSTAcasti Pharma3231.37 millionN/ANot OptionableAPSAptose Biosciences312.55 millionN/ANot OptionableGSDDevonian Health Group62.78 millionN/ANot OptionableLTYLiberty BiopharmaN/A10.77 millionN/ANot OptionableAPS, LTY, GSD, and ACST HeadlinesRecent News About These CompaniesTelefonica Is Said to Draw Up Plans for Liberty’s VMO2 StakeMay 15, 2025 | bloomberg.comMoms for Liberty wants funds cut to Alabama libraries that let kids check out ‘pornographic material’January 11, 2024 | al.comARight wing Moms for Liberty group making moves in staunchly blue ManhattanJanuary 9, 2024 | nydailynews.comWhy Liberty Latin America Ltd. (LILA) Has an Undervalued Rating?January 3, 2024 | msn.comABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing FeesJanuary 3, 2024 | markets.businessinsider.comLiberty Hospital is still recovering systems days after cyber attackDecember 29, 2023 | bizjournals.comMicrobot’s Liberty Robotic System Meets Objectives in Pivotal Preclinical StudyDecember 28, 2023 | evtoday.comERedhill Biopharma Ltd ADRDecember 27, 2023 | morningstar.comMMoms for Liberty faces growing challenges amid Florida sex scandalDecember 23, 2023 | news.yahoo.comOne Liberty (OLP) Completes Asset Sale Worth $63M in 2023December 22, 2023 | msn.comDelayed Liberty Hospital surgery could cost patient thousands if IT issues continueDecember 20, 2023 | msn.comLiberty Travel Partners with Affirm to Bring Travelers a More Flexible Way to Book TripsDecember 18, 2023 | tmcnet.comLiberty 99, St. Andrews 26December 16, 2023 | sfgate.comHere's Why Liberty Park Capital's Short Position in Powell Industries (POWL) DetractedDecember 16, 2023 | msn.comLiberty Home Guard reviewDecember 13, 2023 | usatoday.comLiberty Shoes Ltd (LIBERTSHOE) Share PriceDecember 12, 2023 | businesstoday.inBLiberty Media to merge unit with SiriusXM to create new public companyDecember 12, 2023 | reuters.comMoms for Liberty's vision for America's future is narrow and dark. Why not help kids?December 7, 2023 | news.yahoo.comLDDFF Liberty Defense Holdings, Ltd.November 29, 2023 | seekingalpha.comRedHill Biopharma Shares Double on FDA's 5-Year Market Exclusivity GrantNovember 27, 2023 | marketwatch.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesGold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?By Nathan Reiff | June 29, 2026Can Trupanion Turn Pet Insurance Loyalty Into Real Earnings?By Peter Frank | June 18, 2026Why Kroger's Giant Eagle Deal Could Change EverythingBy Jeffrey Neal Johnson | July 3, 2026Fiserv’s Debit Network Talks Raise a Bigger Question for Visa and MastercardBy Jeffrey Neal Johnson | July 9, 2026MarketBeat Week in Review – 07/06 - 07/10By MarketBeat Staff | July 11, 2026APS, LTY, GSD, and ACST Company DescriptionsAcasti Pharma CVE:ACSTC$0.58 +0.01 (+1.75%) As of 03/27/2023Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.Aptose Biosciences TSE:APSC$2.40 0.00 (0.00%) As of 07/3/2026Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.Devonian Health Group CVE:GSDC$7.01 -3.05 (-30.32%) As of 01:27 PM EasternDevonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.Liberty Biopharma CVE:LTYC$2.00 +2.00 (+∞) As of 10/10/2018Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector GE Aerospace Faces a Prove-It Moment in Q2 Earnings Sandisk: What the Chart Is Trying to Tell Us Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Has Broadcom Become Too Expensive for Its AI Story? 3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
